Nature and impact of in-hospital complications associated with persistent critical illness
Boris Tseitkin1, Johan Mårtensson1,2, Glenn M Eastwood1,3
1Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.
Insights
Patients with persistent critical illness (PerCI) experience more in-hospital complications but not a higher rate when adjusted for exposure. Identifying these complications can guide preventative strategies for high-risk ICU patients.
Area of Science:
- Critical Care Medicine
- Intensive Care Unit (ICU) Management
- Patient Outcomes Research
Background:
- Persistent critical illness (PerCI) is defined as an ICU stay of 10 days or more.
- The specific in-hospital complications associated with PerCI are not well understood.
- Understanding these complications is crucial for improving patient care and outcomes.
Purpose of the Study:
- To determine if PerCI is linked to a higher prevalence and specific types of in-hospital complications.
- To compare complication rates between patients with PerCI and those without.
- To identify potential targets for intervention and prevention strategies.
Main Methods:
- A single-centre, retrospective, observational case-control study was conducted.
- 1200 patients admitted to a tertiary ICU between 2010 and 2015 were analyzed.
- Patients were categorized into PerCI (ICU stay ≥ 10 days) and control groups.
Main Results:
- PerCI patients had significantly longer ICU and hospital stays compared to controls.
- Higher rates of acute renal replacement therapy, reintubation, and tracheostomy were observed in PerCI patients.
- Despite increased complications, hospital mortality rates were similar between PerCI and control groups.
Conclusions:
- PerCI is associated with a higher prevalence of specific in-hospital complications.
- Exposure-adjusted complication rates were lower in PerCI patients, suggesting efficient care despite complexity.
- Certain complications in PerCI patients may be preventable, offering targets for future interventions.
Abstract:
Background: Persistent critical illness (PerCI) is defined as an intensive care unit (ICU) admission lasting ≥ 10 days. The in-hospital complications associated with its development are poorly understood. Aims: To test whether PerCI is associated with a greater prevalence, rate and specific types of in-hospital complications. Methods: Single-centre, retrospective, observational case-control study. Results: We studied 1200 patients admitted to a tertiary ICU from 2010 to 2015. Median ICU length of stay was 16 days (interquartile range [IQR], 12-23) for PerCI patients v 2.3 days (IQR, 1.1-3.7) for controls, and median hospital length of stay was 41 days (IQR, 22-75) v 8 days (IQR, 4-17) respectively. A greater proportion of PerCI patients received acute renal replacement therapy (37% v 6.8%) or underwent reintubation (17% v 1%) and/or tracheostomy (36% v 0.6%); P < 0.0001. Despite these complications, PerCI patients had similar hospital mortality (29% v 27%; P = 0.53). PerCI patients experienced a greater absolute number of complications (12.1 v 4.0 complications per patient; P < 0.0001) but had fewer exposure-adjusted complications (202 v 272 complications per 1000 hospital bed-days; P < 0.001) and a particularly high overall prevalence of specific complications. Conclusions: PerCI patients experience a higher prevalence, but not a higher rate, of exposure-adjusted complications. Some of these complications appear amenable to prevention, helping to define intervention targets in patients at risk of PerCI. Funding: Austin Hospital Intensive Care Trust Fund.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Pneumonia II: Pathophysiology


